The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis
Launched by INTEGRATIVE SKIN SCIENCE AND RESEARCH · Jul 4, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well computer-generated images can evaluate skin conditions like acne, rosacea, melasma, and seborrheic dermatitis. The goal is to see if these computer assessments match the evaluations made by expert dermatologists. This research could help improve the way we assess and treat these common skin issues.
Adults aged 18 and older with any of these skin conditions may be eligible to join the study. However, people who are currently in prison, unable to give consent, or have facial markings like piercings or tattoos that could interfere with the imaging are not eligible. Participants can expect to have their skin photographed using a special imaging system and will be part of a study that aims to improve our understanding of these skin conditions. Your involvement could contribute to better treatment methods in the future!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults with acne, rosacea, melasma or seborrheic dermatitis
- Exclusion Criteria:
- • Prisoners
- • Adults unable to consent
- • Artificial facial markings on day of facial photography (such as piercings and tattoos) that may interfere with imaging in the opinion of the investigator
About Integrative Skin Science And Research
Integrative Skin Science and Research is a leading clinical trial sponsor dedicated to advancing dermatological science through innovative research and development. With a focus on integrative approaches that combine traditional and contemporary methodologies, the organization conducts rigorous clinical trials aimed at evaluating the safety and efficacy of novel skin therapies. Committed to enhancing patient care, their multidisciplinary team collaborates with healthcare professionals and researchers to ensure the highest standards of scientific integrity and ethical practices in all studies. By fostering partnerships with academic institutions and industry leaders, Integrative Skin Science and Research strives to contribute significantly to the field of dermatology and improve outcomes for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sacramento, California, United States
Patients applied
Trial Officials
Raja Sivamani, MD, MS, AP
Principal Investigator
Integrative Skin and Research
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported